Greenspace Herbs: Bringing Science and Precision to Ayurveda’s Next Chapter

As the herbal extracts and nutraceuticals industry moves towards greater scientific validation, consistency and transparency, Greenspace Herbs is working to bring traditional Ayurvedic knowledge closer to modern research. In this conversation with Indian Startup Times, Shafiulla Hirehal Nuruddin shares his professional journey, the company’s evolution, its science-led approach to herbal ingredients, and his vision for the future of wellness.

Q1. Could you tell us about your professional journey and the experiences that led you into the herbal extracts and nutraceuticals industry? How has your journey shaped your approach to business and innovation?

I am trained as an industrial engineer, so my first instinct has always been to look for the system behind a result. Plants, though, were never far away. I grew up in a setting where herbs were part of everyday life and everyday conversation, and over the last three decades that early familiarity turned into a profession.

What really pulled me in was a very engineering-style question. Why does the same herb, from the same region, processed the same way, behave differently from one batch to the next? If chemistry alone explained everything, that inconsistency should not exist. That question took me from manufacturing herbal extracts into research, and eventually into building Quantum Ayurveda.

The journey has shaped one simple rule in how I run the business: measure before you claim. Innovation in herbal wellness matters only if it can be tested, repeated, and explained to a sceptical buyer. My engineering training gave me the discipline; Ayurveda gave me the depth of knowledge worth applying that discipline to.

Q2. Greenspace Herbs has a history spanning around two decades. What was the original vision behind the company, and how has that vision evolved over the years?

The original vision was straightforward: to manufacture herbal extracts that people could trust. At the time, the Indian herbal sector had enormous knowledge but uneven quality, and we wanted to be a dependable, GMP-certified source of natural ingredients that genuinely improved health and quality of life.

That foundation has not changed, but the ambition has grown. For years, India has been seen as the world’s supplier of raw herbs and traditional formulations. Over time, I began to feel that we were selling our heritage short. The question shifted from “How do we make a good extract?” to “How do we help the world understand why these plants work, and make them work better?”

That is what led to Quantum Ayurveda, our AYUQUANTA 7™ framework, the VignanaVeda research centre and our US presence. Today the vision is for Greenspace to be known not only as a manufacturer, but as an Indian company exporting science, not just heritage.

Q3. You have experience across manufacturing, sales, and business operations. What key lessons from these roles have helped you lead Greenspace Herbs and guide its growth?

Each role taught me something I still use every day.

Manufacturing taught me that consistency is a promise. A customer may forgive a delay, but they will not forgive a batch that behaves differently from the last one. That is why so much of our investment has gone into analytical systems and quality control.

Sales taught me that a business customer is not really buying an ingredient. They are buying certainty: certainty about quality, documentation, supply and the story they will tell their own consumers. If you understand that, you stop selling products and start solving problems.

Operations taught me patience and realism. Good science still has to be delivered on time, within budget, through a supply chain that depends on farmers, seasons and logistics.

Together, these lessons keep me grounded. Big ideas are important, but a company grows on the strength of small promises kept consistently.

Q4. Greenspace Herbs is moving beyond the traditional marketing narrative around Ayurveda towards a more science-led approach. What inspired this shift, and why do you believe it matters for the future of herbal wellness?

For a long time, Ayurveda has been marketed on nostalgia: ancient, natural, time-tested. Those words are true, but they are no longer enough. When we speak to formulators in the US, Europe or Asia, the first question is never about how old a tradition is. It is about the data: what is in the extract, how consistent it is, how well it is absorbed and what evidence supports it.

The shift was inspired by those conversations. I realised that if Ayurveda continues to rely only on its heritage, it will remain a source of raw material for others to research, brand and profit from. If it speaks the language of science, it can lead.

This matters because consumers have become more informed and more sceptical, and regulators are becoming more demanding. A science-led approach does not dilute Ayurveda. It protects it, by giving its insights the evidence they deserve and the credibility they need to compete globally.

Q5. The company uses the AYUQUANTA 7™ framework and focuses on the concept of ‘vibrational language’ and plant compounds. Could you explain this approach in simple terms and how it is applied in your work?

The simplest way to put it is this: every plant compound has a chemical identity and an energetic identity. Conventional extraction looks only at the first. Two extracts can look almost identical on a chemical report and still behave differently in the body. We believe part of that difference lies in the compound’s energetic state, which we call its vibrational language.

This is not a mystical idea. These vibrational signatures can be read using established analytical tools such as spectroscopy, and over the years we have built a large library of bioactive signatures.

AYUQUANTA 7™ is the framework that guides how we work with that language. In practical terms, we first map a plant’s signature, then use controlled, calibrated energy inputs to prime the compound while keeping its natural chemistry intact and finally stabilise that state so it holds through storage and delivery. Every step is checked analytically. The goal is an ingredient that the body recognises and uses more efficiently, which can mean better absorption at lower doses.

Q6. How does Greenspace Herbs combine traditional Ayurvedic knowledge with modern research and development? What processes help you assess the quality, consistency, and efficacy of your herbal ingredients?

We start with the classical texts. Charaka and Sushruta documented herb–body interactions with remarkable detail, and that is our first reference for which plants to work with and why. We then cross-check those classical indications against modern literature and our own bioenergetic data.

On quality and consistency, we rely on layered testing. Raw materials are authenticated and profiled before processing. During and after processing, we use techniques such as XRD, FTIR, DSC and Raman spectroscopy to understand both the composition and the physical state of the ingredient. AI-driven quality controls help us spot variation that the human eye would miss. Our manufacturing is GMP-certified by the Ministry of AYUSH.

Efficacy is where we are most careful. Tradition and lab data show us where to look, but we must validate outcomes. That is the purpose of VignanaVeda, our dedicated research centre, which works on the scientific validation of Ayurvedic ingredients with research and clinical partners. Our principle is that every formulation decision should trace back either to a documented classical principle or to a measurable finding.

Q7. Greenspace Herbs serves B2B wellness brands and manufacturers. What are the biggest challenges these businesses face when sourcing and communicating the value of herbal ingredients, and how does your company help address them?

The first challenge is trust in the supply. Herbal ingredients vary by season, region and processing, and adulteration remains a real issue in the industry. Brands need to know that what they bought last quarter is exactly what they will receive next quarter.

The second is bioavailability. Many well-known botanicals, curcumin being the classic example, are not absorbed well. Brands end up using higher doses to compensate, which affects cost, capsule size and consumer experience.

The third is differentiation. When every shelf has ashwagandha or turmeric, how does a brand explain why its product is different? Most suppliers give them a certificate of analysis and nothing more.

We try to solve all three. Our branded QA ingredients come with detailed analytical documentation and consistent batch performance. Our processing is designed to address absorption. And because each ingredient has a clear scientific story behind it, our partners have something credible and specific to communicate to their own consumers, rather than relying on generic claims.

Q8. Greenspace Herbs has expanded its footprint across domestic and international markets. What have been the key drivers of this growth, and how do customer needs differ across markets?

The biggest driver has been demand for botanicals that are genuinely differentiated and backed by data. Global supplement brands are actively looking for the next generation of herbal ingredients, and our presence at platforms such as SupplySide Global and Vitafoods opened many of those conversations.

Last year, we opened our US office in New Jersey to work more closely with customers there, while all research, processing and manufacturing remain in Bengaluru. We have also continued to invest in our Bengaluru infrastructure to keep pace.

Customer needs differ quite clearly. In the US, buyers want documentation, mechanism and a strong scientific narrative, and the strongest interest has come from women’s health, cognition and mental wellness, with sports nutrition close behind. In Europe, the emphasis is on regulatory compliance, traceability and clean labels. In India, there is natural familiarity with Ayurveda, but also price sensitivity and a growing premium segment that wants proof, not just tradition. Our job is to keep the science consistent and adapt how we present it to each market.

Q9. In a competitive herbal extracts and nutraceuticals industry, what differentiates Greenspace Herbs from other manufacturers? How do you build trust with business customers and long-term partners?

Most of the industry competes on price and standardisation percentages. We have chosen to compete on knowledge. Quantum Ayurveda and AYUQUANTA 7™ are our own platform, developed in India, and our research, processing and manufacturing sit under one roof in Bengaluru. That gives us control over quality and the ability to keep innovating rather than simply supplying commodities.

Trust, in my experience, is built in three ways. First, by showing the work. We share our analytical data openly and invite scrutiny, because a new scientific approach should be questioned. Second, by being consistent, batch after batch, so partners can build products around us with confidence. Third, by treating customers as partners. Many of our relationships involve working together on formulation and positioning, not just shipping an ingredient.

In a B2B business, your reputation is the sum of every order you deliver. We take that seriously.

Q10. What has been one of the most significant challenges in building and growing Greenspace Herbs, and what did that experience teach you about leadership, product development, or the herbal wellness industry?

The hardest challenge has been introducing a framework that the industry had never seen before. The word “quantum” has been overused in wellness marketing, and when we first presented Quantum Ayurveda, the reaction from many buyers and scientists was understandable wariness.

We could have softened the idea or wrapped it in vague marketing language. Instead, we chose to lead with instrumentation and data: the spectroscopy, the analytical reads, the absorption work.

Conversations changed once people could see what we were measuring. It took longer, but the credibility we built that way is far more durable.

That experience taught me that leadership in a new field needs conviction and humility in equal measure. Conviction to keep going when people doubt you, and humility to accept that the doubt is healthy and that you must earn belief. On product development, it reinforced that no ingredient should leave our facility unless we can explain, with evidence, what it does differently.

Q11. How do you see the herbal extracts, Ayurveda, and nutraceuticals sectors evolving over the next five years, particularly as consumers increasingly look for science-backed wellness products?

I think the next five years will separate commodity suppliers from knowledge-led companies. Consumers now read labels, search for studies and question claims. Regulators across markets are tightening standards. Generic “natural” positioning will no longer be enough.

We will see a strong move towards branded, clinically supported ingredients, better delivery and absorption, and much tighter traceability from farm to finished product. AI will play a growing role, not only in personalisation but in decoding how plants work and in predicting how formulations will perform. Areas such as women’s health, cognitive wellbeing, metabolic health and healthy ageing will lead demand.

For India, this is a turning point. We have the biodiversity, the classical knowledge and a growing base of scientific talent, including Indian scientists returning from abroad. If we invest in evidence and intellectual property, India can move from being the world’s herb supplier to being its source of next-generation wellness science.

Q12. What are the key priorities for Greenspace Herbs over the next three to five years? What advice would you give to entrepreneurs building businesses at the intersection of traditional knowledge, science, and modern wellness?

Our priorities are clear. First, deepening validation through VignanaVeda and our research and clinical partners, so that every ingredient in our portfolio is supported by stronger evidence. Second, expanding our portfolio of QA ingredients, building on launches such as our Morimin™ moringa blend. Third, growing our presence in the US, Europe and Asia while building a stronger base in India. And fourth, investing in people, because this work needs scientists who are comfortable working across disciplines.

My advice to entrepreneurs in this space is to respect both sides equally. Do not treat tradition as a marketing label, and do not treat science as decoration. Build the evidence before you build the campaign. Be prepared for scepticism and welcome it, because it makes your work better. And be patient. The intersection of traditional knowledge and modern science is one of the most exciting places to build a business today, but credibility here is earned slowly and lost very quickly.

Interview By : Palak

Picture of Indian Startup Times

Indian Startup Times

Leave a Reply

Your email address will not be published. Required fields are marked *